Ras oncogene transformed and nontransformed cell populations are each heterogeneous but respond differently to the chemotherapeutic drug cytosine arabinoside (Ara-C)

Cancer Chemotherapy and Pharmacology

Volumn 39, Issue 5, 1997, Pages 445-451

  Axelrod, David E ^a   Gusev, Yuriy ^a,b   Gamel, John W ^c  

^a RUTGERS UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Louisville School of Medicine   (United States)

Author keywords

Cytosine arabinoside; Heterogeneity; Ras oncogene

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE;

ANIMAL CELL; ARTICLE; CELL GROWTH; CELL HETEROGENEITY; CELL POPULATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG RESPONSE; MOUSE; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL;

3T3 CELLS; ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CULTURE TECHNIQUES; CYTARABINE; GENES, RAS; KINETICS; MICE; REPRODUCIBILITY OF RESULTS;

EID: 0031054397     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050596     Document Type: Article

References (32)

1. Axelrod DE, Kuczek T (1989) Clonal heterogeneity in populations of normal and tumor cells. Comput Math Applic 18:871
2. Axelrod DE, Milcos-Livanos E, Vibhukar N (1991) Colony size heritability: a new parameter for characterizing proliferating populations of normal and tumor cells. In: Arino A, Axelrod DE, Kimmel M (eds) Mathematical population dynamics. Marcel Dekker, New York, p 713
3. Axelrod DE, Gusev Y, Kuczek T (1993) Persistence of cell cycle times over many generations as determined by heritability of colony sizes of ras oncogene-transformed and non-transformed cells. Cell Prolif 26:235
4. Cavalli-Sforza LL, Bodmer WE (1971) The genetics of human populations. Freeman, San Francisco, p 573
5. Clark GM, Von Hoff DD (1983) Human tumour drug sensitivity testing in vitro. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro, techniques and clinical applications. Academic Press, New York, p 225
6. Der CJ, Krontiris TG, Cooper GM (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc Natl Acad Sci USA 79:3637
7. Dexter DE, Kowaiski HM , Blazar BA , Fligiel Z, Vogel R, Heppner GK (1978) Heterogeneity of tumor cells from a single mouse mammary tumor. Cancer Res 38:3274
8. Gamel J, Axelrod DE (1991) Inheritance and regression toward the mean in proliferating cell populations. Cell Prolif 24:281
9. Grundel R, Rubin H (1988) Maintenance of multiplication rate stability by cell populations in the face of heterogeneity among individual cells. J Cell Sci 91:571
10. Gusev Y, Axelrod DE (1995) Evaluation of models of inheritance of cell lifetimes: computer simulation and recloning experiments. In: Arino A, Axelrod DE, Kimmel M (eds) Mathematical population dynamics: analysis of heterogeneity. Wuerlz, Winnipeg, p 97
11. Gusev Y, Axelrod DE (1996) Simulation of drug-inhibited cell proliferation with a model of clonal inheritance of cell lifetimes. In: Lakshmikantham V (ed) World Congress of Nonlinear Analysts '92. Walter de Gruyler, Berlin, p 3455
12. Hartl DL, Clark AG (1989) Principles of population genetics. Sinauer, Sunderland, Massachusetts, p 430
13. Heppner GH, Dexter DE, DeNucci T, Miller FR, Calabresi P (1978) Heterogeneity in drug sensistivity among tumor cell subpopulations of a single mammary tumor. Cancer Res 38:3758
14. Hill BT (1983) An overview of clonogenic assays for human tumour biopsies. In: Dendy PP, Hill BT (eds) Human tumour drug sensitivity testing in vitro, techniques and clinical applications. Academic Press, New York, p 91
15. Hughes WH (1955) The inheritance of differences in growth rate in Escherichia coli. J Gen Microbiol 12:265
16. Jainchill JL, Aaronson SA, Todaro GE (1969) Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol 4:549
17. Kuczek T, Axelrod DE (1986) The importance of clonal heterogeneity and interexperiment variability in modeling the eukaryotic cell cycle. Math Biosci 79:87
18. Kuczek T, Axelrod DE (1987) Tumor cell heterogeneity: divided-colony assay for measuring drug response. Proc Natl Acad Sci USA 84:4490
19. Leith JT, Dexter DE (1986) Mammalian tumor cell heterogeneity. CRC Press, Boca Raton
20. Rubin H (1987) The sources of heritable variation in cellular growth capacities. Cancer Metastasis Rev 6:85
21. Rubin H (1990) The significance of biological heterogeneity. Cancer Metastasis Rev 9:1
22. Rustum YM, Slocum HK (1988) Predictive tests for cancer chemotherapy and the problem of tumor cell heterogeneity. In: Hall TC (ed) Prediction of response to cancer therapy. Alan R, Eiss, New York, p 119
23. Schlag P, Schremi W (1982) Heterogeneity in growth pattern and drug sensitivity of primary tumor and metastases in the human tumor colony-forming assay. Cancer Res 42:4086
24. Shoemaker RH, Wolpert-DeFilippes MK, Kern DH, Lieber MM, Makuch RW, Melnick NR, Miller WT, Salmon SE, Simon RM, Venditti JM, Von Hoff DD (1985) Application of a human tumor colony-forming assay to new drug screening. Cancer Res 45:2145
25. Tabin CJ, Bradley SM, Bargmann CI, Weinberg RA, Papageorge AG, Scolnick EM, Dhar R, Lowy DR, Chang EH (1982) Mechanism of activation of a human oncogene. Nature 300:143
26. Tanigawa N, Mizuno Y, Hashimura T, Honda K, Satomura K, Hikasa Y, Niwa O, Sugahara T, Yoshida O, Kern DH, Morton DL (1984) Comparison of drug sensitivity among tumor cells within a tumor, between primary tumor and metastases, and between different metastases in the human tumor colony-forming assay. Cancer Res 44:2309
27. Trope C (1982) Different susceptibilities of tumor cell subpopulations to cytotoxic agents. In: Fidler IJ, White RJ (eds) Design of models for testing cancer therapeutic agents. Van Nostrand, New York, p 64
28. Trope C (1982) Different susceptibilities of tumor cell subpopulations to cytoxic agents and therapeutic consequences. In: Owens AH, Coffey DS, Baylin SB (eds) Tumor cell heterogeneity. Academic Press, New York, p 147
29. Tsuruo T, Fidler IJ (1981) Differences in drug sensitivity among tumor cells from parental tumors, selected variants, and spontaneous metastases. Cancer Res 41:3058
30. Wheals AE, Lord PG (1992) Clonal heterogeneity in specific growth rate of Saccharomyces cerevisiae cells. Cell Prolif 25:217
31. Yung W-KA, Shapiro JR, Shapiro WR (1982) Heterogeneous chemosensitivities of subpopulations of human glioma cells in culture. Cancer Res 42:992
32. Zar JH (1984) Biostatistical Analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ